NOTTA®
Description
General characteristics:
basic physical and chemical properties: transparent, slightly yellow or greenish-yellow solution without peculiar smell, with a slight taste of oats;
composition: 100 ml of drops contains: Avena sativa D1 20 ml, Phosphorus D12 10 ml, Chamomilla D12 10 ml, Coffea D12 10 ml, Zincum valerianicum D12 10 ml, ethanol 43% by weight;
1 ml contains 25 drops
Form of issue. Drops for oral administration.
Pharmacotherapeutic group. Complex homeopathic drug. ATC code N05CM.
The pharmacological properties.
Pharmacodynamics. The drug notta® has tranquilizing (anxioliticeski) effect without the effects of muscle relaxation and sedation, has antidepressant, vegetal stabilizing and psychoactively action. Improves the regulation of affective activities by strengthening the brake function of the psyche.
Eliminates anxiety and fear, relieves nervous tension and anxiety. Improves mood. Has wegetotropona activity, contributes to the normalization of autonomic security and reactivity of the autonomic nervous system provides a quick and stable effect on autonomic disorders. Restores physiological sleep and circadian cycle "sleep-Wake": eliminates as pre and intra, postcanon disorders, improves the quality of nighttime sleep, without difficulty awakening, drowsiness or lethargy during the day.
Notta® eliminates asthenic syndrome, increases concentration, the ability to clear thinking, memory. Strengthens nervous system and improves the individual compensatory potential of the psyche, capacity for work, resistance to psycho-emotional loads, other indicators of quality of life.
Pharmacokinetics. Has not been studied.
Indications.
Psychosomatic disorders and of any conditions after suffering a nervous overstrain or stress, accompanied by anxiety, depression, insomnia, nervous exhaustion. In Pediatrics: in treatment of consequences of perinatal lesions of the Central nervous system, hypertension lcontinue syndrome, neurogenic bladder, autonomic dysfunction syndrome, asthenic syndrome of various etiology and syndrome of increased neuro-reflex excitability.
Method of application and doses.
Adults and teenagers: 10 drops of the drug in pure form or diluted in 1 tablespoon of water;
children under 12 years: 5-7 drops of the drug diluted in 1 tablespoon of water;
children up to 1 year: 1 drop of the drug diluted in 1 tablespoon of water or milk.
Take 3 times a day 30 minutes before or one hour after a meal.
At the beginning of treatment, and in cases requiring a rapid easing of symptoms can receive the drug every half-hour in adults and adolescents 8 - 10 drops children up to 12 years old 3 - 5 drops diluted in 1 tablespoon of water, children under 1 year 1 drop diluted in 1 tablespoon of water or milk to improve the condition, but not more than 8 times, then take 3 times a day.
To enhance efficiency it is recommended to hold the drug some time in the mouth before swallowing.
The course of treatment depending on the severity of the condition and duration of the disease is 1 - 4 months. If necessary, repeat the course.
Side effects. Not detected.
Contraindications. Hypersensitivity to any component of the drug.
Features of the application. At the beginning of treatment may appear slight manifestations of the amplification of symptoms, not requiring discontinuation of the drug.
Information regarding any risk to the fetus and the child from the use of drugs during pregnancy and lactation is still not registered. The drug can be used during pregnancy and lactation if the benefits of the drug outweighs the potential risk.
Cases of addiction or dependence with prolonged use have not been identified.
Notta® does not cause lethargy, drowsiness by day, consciousness disorders or the sexual sphere, therefore, can be recommended for people in all professions, including those who require greater attention, rapid motor and mental reactions.
Interaction with other medicines.
A clinically significant drug interaction notta® with other drugs is not established. The drug can be combined with other medicines and methods of treatment.
While the use of the drug notta® with psychotropic drugs (including anxiolytics, hypnotics) admission and the last dose can be reduced.
The expiration date. 5 years. Do not use the preparation after expiry date stated on the package.
Since notta® contains natural plant components, storage may be a slight change of taste, the transparency or the color of the solution that does not reduce the effectiveness of the drug.
The storage conditions. Keep out of the reach of children in a tightly closed vial in original carton at a temperature not exceeding 30°C.
Packing. Vials of 20, 50 and 100 ml dropping in a cardboard box.